Bulletin
Investor Alert

Pacira BioSciences Inc.

NAS: PCRX

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 27, 2021, 5:25 p.m.

/zigman2/quotes/202929053/composite

$

51.66

Change

0.00 0.00%

Volume

Volume 57,494

Quotes are delayed by 20 min

/zigman2/quotes/202929053/composite

Previous close

$ 52.41

$ 51.66

Change

-0.75 -1.43%

Day low

Day high

$51.00

$52.64

Open

52 week low

52 week high

$45.05

$80.00

Open

Annual Financials for Pacira BioSciences Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 276.37M286.63M337.28M421.03M429.65M
Cost of Goods Sold (COGS) incl. D&A 110.1M87.92M86.85M112.42M125.19M
COGS excluding D&A 97.19M74.08M73.68M92.84M105.29M
Depreciation & Amortization Expense 12.92M13.83M13.17M19.58M19.91M
Depreciation 12.82M13.83M13.17M13.87M12.04M
Amortization of Intangibles 100,000--5.7M7.87M
Gross Income 166.27M198.72M250.43M308.61M304.45M
20162017201820192020 5-year trend
SG&A Expense 191.19M211.68M225.85M272.9M252.94M
Research & Development 45.68M57.29M55.69M72.12M59.42M
Other SG&A 145.51M154.39M170.17M200.78M193.52M
Other Operating Expense -----
Unusual Expense 7.1M15.7M8.66M30.93M17.34M
EBIT after Unusual Expense (32.02M)(28.67M)15.92M4.78M34.18M
Non Operating Income/Expense (82,000)167,000(888,000)724,0006.95M
Non-Operating Interest Income 1.32M4.08M6.5M7.38M4.63M
Equity in Affiliates (Pretax) -----
Interest Expense 7.06M18.05M21.95M23.63M25.67M
Gross Interest Expense 8.56M19.15M22.64M23.65M28.06M
Interest Capitalized 1.5M1.1M689,00020,0002.39M
Pretax Income (37.84M)(42.47M)(425,000)(10.75M)20.09M
Income Tax 105,000140,00046,000268,000(125.43M)
Income Tax - Current Domestic 105,000140,00046,0002.1M1.18M
Income Tax - Current Foreign -----
Income Tax - Deferred Domestic ---(1.83M)(126.61M)
Income Tax - Deferred Foreign -----
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income (37.95M)(42.61M)(471,000)(11.02M)145.52M
Minority Interest Expense -----
Net Income (37.95M)(42.61M)(471,000)(11.02M)145.52M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries (37.95M)(42.61M)(471,000)(11.02M)145.52M
Preferred Dividends -----
Net Income Available to Common (37.95M)(42.61M)(471,000)(11.02M)145.52M
EPS (Basic) (1.02)(1.07)(0.01)(0.27)3.41
Basic Shares Outstanding 37.24M39.81M40.91M41.51M42.67M
EPS (Diluted) (1.02)(1.07)(0.01)(0.27)3.33
Diluted Shares Outstanding 37.24M39.81M40.91M41.51M43.68M
EBITDA (12.01M)864,00037.74M55.29M71.42M
Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.